K. Park
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 47
- Colorectal Cancer Treatments and Studies 20
- Lung Cancer Research Studies 13
- Cancer Immunotherapy and Biomarkers 12
- HER2/EGFR in Cancer Research 8
-
- Lung Cancer Treatments and Mutations 40
- Lung Cancer Diagnosis and Treatment 8
- Gastric Cancer Management and Outcomes 6
- Co-authors
- Yi‐Long Wu (9 shared papers)Bruno Coudert (1 shared paper)P. Gopalakrishna (1 shared paper)Dariusz M. Kowalski (4 shared papers)Giuseppe Giaccone (1 shared paper)Tudor–Eliade Ciuleanu (2 shared papers)Wolfram Brugger (1 shared paper)Kihyun Kım (2 shared papers)
- Journals
- Annals of Oncology (30 papers)Journal of Thoracic Oncology (12 papers)Journal of Clinical Oncology (4 papers)Lung Cancer (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- South KoreaUnited StatesSpain
In The Last Decade
K. Park
50 papers receiving 769 citations
Peers
Comparison fields: 5 of 62
- Oncology 560
- Pulmonary and Respiratory Medicine 448
- Hematology 72
- Cancer Research 73
- Pathology and Forensic Medicine 76
Countries citing papers authored by K. Park
This map shows the geographic impact of K. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Park more than expected).
Fields of papers citing papers by K. Park
This network shows the impact of papers produced by K. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Park. The network helps show where K. Park may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 118 | |
| 2 | 2011 | 77 | |
| 3 | 2019 | 66 | |
| 4 | 2002 | 61 | |
| 5 | 2016 | 56 | |
| 6 | 2008 | 54 | |
| 7 | 1986 | 51 | |
| 8 | 2010 | 43 | |
| 9 | 2007 | 42 | |
| 10 | 2015 | 28 | |
| 11 | 2014 | 20 | |
| 12 | 2018 | 18 | |
| 13 | 2010 | 16 | |
| 14 | 2021 | 13 | |
| 15 | 2015 | 12 | |
| 16 | 2018 | 11 | |
| 17 | 2019 | 7 | |
| 18 | 2020 | 6 | |
| 19 | 2019 | 6 | |
| 20 | 2019 | 6 |
About K. Park
K. Park is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Molecular Biology, having authored 54 papers that have together received 781 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (40 papers), Colorectal Cancer Treatments and Studies (20 papers), Lung Cancer Research Studies (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), HER2/EGFR in Cancer Research (8 papers), Lung Cancer Diagnosis and Treatment (8 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Oncology (560 citations), Pulmonary and Respiratory Medicine (448 citations), Hematology (72 citations), Cancer Research (73 citations) and Pathology and Forensic Medicine (76 citations). K. Park has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include Yi‐Long Wu, Bruno Coudert, P. Gopalakrishna, Dariusz M. Kowalski, Giuseppe Giaccone, Tudor–Eliade Ciuleanu, Wolfram Brugger, Kihyun Kım, Federico Cappuzzo and Baek‐Yeol Ryoo. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Journal of Clinical Oncology, Lung Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.